Jose Ramon Gonzalez Porras
- Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutationJose Ramon Gonzalez-Porras
Department of Hematology, University Hospital of Salamanca, Spain
Blood Coagul Fibrinolysis 17:23-8. 2006..6% (95% confidence interval, 0.2-0.9). We have identified a group of patients with DVT but at very low risk of re-thrombosis in whom an extended secondary thromboprophylaxis should be carefully considered...
- Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphismJ R Gonzalez-Porras
Department of Hematology, University Hospital of Salamanca, Paseo de San Vicente, 58 182, Salamanca, 37007, Spain
Thromb Res 119:691-8. 2007..37 mumol/L) [HR=2.5; (95% CI, 1.1-4.7); p=0.04]. Elevated plasma homocysteine level at admission is an independent risk factor for RCE after the first episode of ACS in young patients irrespective of the status of MTHFR C677T...
- Homocysteine and outcome in young patients with acute coronary syndromesFrancisco Martin-Herrero
Cardiology Department, University Hospital, Salamanca, Spain
Int J Cardiol 118:183-8. 2007..Despite the well-known pro-thrombotic and pro-inflammatory plasma homocysteine effects, it remains uncertain whether these effects can be associated with an adverse cardiac outcome in young patients admitted with acute coronary syndromes...